![Will M. de Groot](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Mr. de Groot joined Boston Millennia Partners in August of 2008.
He has worked on international, federal and state public policy issues for healthcare companies including GlaxoSmithKline, Novartis and Millennium Pharmaceuticals.
He has had an extensive career in the public policy arena working both inside and outside of the government sector.
This work was focused on driving legislation/regulation that allowed for a more streamlined delivery of products, services and overall healthcare to patients.
Mr. de Groot has been active in a variety of business organizations including the Massachusetts Biotechnology Council, the New England Council, the Greater Philadelphia Chamber of Commerce, the Boston Chamber of Commerce, the Healthcare Institute of New Jersey, the St. Louis Regional Chamber and Growth Association, the Biotechnology Industry Organization (BIO) and the Pharmaceutical Researcher and Manufactures of America (PHRMA).
He assists the Boston Millennia Partners investment professionals in all aspects of portfolio company selection, ongoing strategy and the execution of that strategy.
Mr. de Groot is a graduate of La Salle University in Philadelphia, Pennsylvania and holds an MBA from the University of Chicago Graduate School of Business.
| Sociétés | Poste | Fin |
|---|---|---|
Millennium Pharmaceuticals, Inc.
 Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures medicines for oncology treatment | Corporate Officer/Principal | - |
GlaxoSmithKline LLC
 GlaxoSmithKline LLC Pharmaceuticals: MajorHealth Technology Engages in research and development, manufacturing of respiratory, immunology, oncology and infectious disease medicines and vaccines | Corporate Officer/Principal | - |
Novartis, Inc.
 Novartis, Inc. Pharmaceuticals: MajorHealth Technology Part of Novartis AG, Novartis, Inc. is a company based in San Francisco, CA. | Corporate Officer/Principal | - |
Boston Millennia Partners
 Boston Millennia Partners Investment ManagersFinance BMP invests in companies located in the United States with revenue of USD 1 - 20 million and an enterprise value of less than USD 50 million. The firm focuses on the healthcare, business services and information technology sectors. It provides financing for early and growth stage capital transactions with an investment size of USD 0.1 - 3 million. The firm makes follow on investments and acts as a lead investor. | Private Equity Investor | - |
Actives
Inactives
Sociétés cotées
Entreprise privées
| Entreprise privées | 6 |
|---|---|
Millennium Pharmaceuticals, Inc.
Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures medicines for oncology treatment | Health Technology |
Novartis, Inc.
Novartis, Inc. Pharmaceuticals: MajorHealth Technology Part of Novartis AG, Novartis, Inc. is a company based in San Francisco, CA. | Health Technology |
Boston Millennia Partners
Boston Millennia Partners Investment ManagersFinance BMP invests in companies located in the United States with revenue of USD 1 - 20 million and an enterprise value of less than USD 50 million. The firm focuses on the healthcare, business services and information technology sectors. It provides financing for early and growth stage capital transactions with an investment size of USD 0.1 - 3 million. The firm makes follow on investments and acts as a lead investor. | Finance |
The University of Chicago
 The University of Chicago Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
LaSalle University
 LaSalle University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
GlaxoSmithKline LLC
GlaxoSmithKline LLC Pharmaceuticals: MajorHealth Technology Engages in research and development, manufacturing of respiratory, immunology, oncology and infectious disease medicines and vaccines | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national
